Advertisement

Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal
This is a free web portal for the life sciences in North America, Europe and Israel... » read more
- Domain Therapeutics Raises $42m Series A Financing (2022-05-12)
Domain Therapeutics, a biopharmaceutical company specializing in the research and development of innovative drugs targeting G Protein-Coupled Receptors (GPCRs) in immuno-oncology, announced today the closing of a US $42m (€39m) series A financing round co-led by Pa... - Consilium SC Appoints Tracy Cheung as Partner (2022-05-06)
Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, is pleased to announce the appointment of Tracy Cheung as a Partner, effective 23 May 2022. Tracy has more than 25 years of communications and lead... - Bico Acquires 3D Bioprinting Company Allegro 3D (2022-05-06)
Adding Allegro 3D to the portfolio enables BICO Bioprinting to strengthen its position as the global leader in providing 3D bioprinters. BICO has a robust portfolio of bioprinters, utilizing extrusion based, 2PP and DLP technologies. BICO has acquired all the ... - Illumina & Deerfield Management Partner for Drug Development (2022-05-05)
First-of-its-kind partnership will identify drug targets and accelerate novel therapy development using genomics and artificial intelligence Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Deerfield Management... - Sidekick Health Raises $55m Series B Led by Novator Ventures (2022-05-05)
International digital therapeutics leader Sidekick Health (www.sidekickhealth.com) today announces that it has raised $55 million in Series B funding. The round was led by London-based venture capital firm Novator Ventures, with additional participation from Wellin... - Hemispherian Raises NOK12.5m Seed Round Led by Meneldor (2022-05-03)
Hemispherian AS (“Hemispherian” or the “Company”), a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics targeting the DNA damage response, is delighted to announce the closure of its successful seed financing. The oversubscri... - Astorg to Acquire CDMO CordenPharma from ICIG (2022-05-02)
Astorg and International Chemical Investors Group (“ICIG”) today announce that they have signed a binding agreement whereby Astorg will acquire CordenPharma (“CordenPharma” or the “Company”), a global leading pharmaceutical CDMO (Contract Development & Manufacturin... - Mark W. Womack New CEO of KBI Biopharma & Selexis SA (2022-05-02)
JSR Life Sciences, LLC (JSR) today announced that Mark W. Womack will serve as the Chief Executive Officer of two of its affiliate companies: KBI Biopharma, a leading global CDMO specializing in drug development and biologics manufacturing, and Selexis SA, an indus... - Merck to Invest €100m in Single-Use Manufacturing in China (2022-04-29)
> Merck’s First-Asia Pacific Mobius® Single-Use Manufacturing Center in Wuxi, China > Investment Supports Biotech Innovation in China > Partnership with Administrative Management Committee of Wuxi National High-Tech Industrial Development Zone to jointly cult... - OMass Therapeutics Raises £75.5m Series B Round (2022-04-28)
> Financing led by new investors, GV, Northpond Ventures and Sanofi Ventures, with existing investors, Syncona, Oxford Science Enterprises, and Oxford University also participating > Investment will advance OMass’s portfolio of novel drugs against highly-validat...
Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!
[LSUS] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in the North America, Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!
» Start here with the latest News!Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top